Literature DB >> 20081237

Role of silent polymorphisms within the dopamine D1 receptor associated with schizophrenia on D1-D2 receptor hetero-dimerization.

Katarzyna Grymek1, Sylwia Łukasiewicz, Agata Faron-Góreckaa, Magdalena Tworzydlo, Agnieszka Polit, Marta Dziedzicka-Wasylewska.   

Abstract

Within the coding region of the dopamine D(1) receptor (D(1)R), two synonymous polymorphisms, D(1)R(G198A) and D(1)R(G1263), have been identified and postulated to correlate with the schizophrenia phenotype. Binding studies revealed that the density of these genetic variants was much lower than the density of wild type D(1)R in the human embryonic kidney (HEK) 293 cell line, used as a model system. From the data obtained using MFOLD software it is apparent that the G198A mutation has a greater impact on the secondary structure of the mRNA, which may affect its translation. However, the G1263A mutation is localized within the serine 421 codon of D(1)R, which is predicted to be a potential site of phosphorylation according to the PHOSIDA database. In order to determine whether the studied synonymous polymorphisms influence the process of dopamine D(1)-D(2) receptors heterodimerization, we employed fluorescence resonance energy transfer (FRET) technology. The dopamine D(2) receptor (D(2)R) was tagged with cyan fluorescence protein and the D(1)R and its genetic variants were tagged with yellow fluorescence protein. The degree of D(1)-D(2) receptor hetero-dimerization was significantly decreased when genetic variants of D(1)R were co-expressed with D(2)R. Since the D(1)R mutations affected the expression levels of the proteins in the cell membrane without affecting the cellular localization of the receptor proteins, we postulated that the D(1)R polymorphisms altered the translation rate and protein structure of the receptor. The altered hetero-dimerization that likely results from the lower expression of these genetic variants of D(1)R with D(2)R may be partially responsible for the association of both G198A and G1263A polymorphisms with the schizophrenia phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20081237     DOI: 10.1016/s1734-1140(09)70164-1

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

1.  A silent mutation in human alpha-A crystallin gene in patients with age-related nuclear or cortical cataract.

Authors:  Bharani K Mynampati; Thungapathra Muthukumarappa; Sujata Ghosh; Jagat Ram
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

2.  Rare-variant pathogenicity triage and inclusion of synonymous variants improves analysis of disease associations of orphan G protein-coupled receptors.

Authors:  Ridge Dershem; Raghu P R Metpally; Kirk Jeffreys; Sarathbabu Krishnamurthy; Diane T Smelser; Michal Hershfinkel; David J Carey; Janet D Robishaw; Gerda E Breitwieser
Journal:  J Biol Chem       Date:  2019-10-18       Impact factor: 5.157

3.  Evidence for limited D1 and D2 receptor coexpression and colocalization within the dorsal striatum of the neonatal mouse.

Authors:  Dominik K Biezonski; Pierre Trifilieff; Jozsef Meszaros; Jonathan A Javitch; Christoph Kellendonk
Journal:  J Comp Neurol       Date:  2015-02-17       Impact factor: 3.215

4.  Association and haplotype analysis of candidate genes in five genomic regions linked to sow maternal infanticide in a white Duroc × Erhualian resource population.

Authors:  Congying Chen; Zhuqing Yang; Yanying Li; Na Wei; Pinghua Li; Yuanmei Guo; Jun Ren; Nengshui Ding; Lusheng Huang
Journal:  BMC Genet       Date:  2011-02-09       Impact factor: 2.797

Review 5.  Pharmacology of Ultrasonic Vocalizations in adult Rats: Significance, Call Classification and Neural Substrate.

Authors:  Stefan M Brudzynski
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.